ID
24096
Description
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Keywords
Versions (2)
- 7/3/17 7/3/17 -
- 7/25/17 7/25/17 -
Uploaded on
July 25, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
Description
RECAPTURE PHASE ENTRY (UNSCHEDULED)
Description
RECAPTURE_MONTH [RCAPMO]
Data type
integer
Measurement units
- Visit Month
Alias
- UMLS CUI [1]
- C3846158
Description
INFORM_CONSENT_DT [ICDT, ICDTF]
Data type
date
Measurement units
- DD/MMM/YY
Alias
- UMLS CUI [1]
- C0021430
Similar models
RECAPTURE PHASE ENTRY (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
C2986440 (UMLS CUI [1,2])